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REVIEW
Dietary supplements and chemical agents have been used for a number of decades among athletes striving to achieve increased strength 
and performance. This has led to a huge, growing market for the food supplement industry. The latter’s products are classified as ‘foods’ 
rather than drugs and are therefore free of the stringent requirements for registration of pharmaceuticals, i.e. no safety and efficacy data 
are required prior to registration. During the past decade, some dietary supplements have been shown to contain pharmaceutically active 
components not adequately identified on their package labels. These pharmaceuticals may have unintentionally entered the product or may 
have been intentionally added. Although the concentrations of these substances may be low and devoid of health or performance-enhancing 
effects, they may lead to positive doping tests. In Part 1 of this two-part review, a selection of the World Anti-Doping Agency-prohibited 
illegal stimulants, i.e. ephedrine, pseudoephedrine, sibutramine and methylhexaneamine, are discussed. Certain food supplement labels 
do mention the presence of natural sources of illegal stimulants, e.g. Ephedra sinica (ephedrine), but do not refer to the chemical entities of 
ephedrine and its analogues as such. The pharmacological adverse effects of stimulants, in particular those on the cardiovascular system, 
are briefly reviewed. Suggestions for avoiding these pitfalls are made.
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While it is well recognised that a balanced diet is 
the foundation for developing optimal training and 
performance, competitive sport and strenuous phys-
ical activity make demands on the human body 
beyond its normal physiological range.[1] Some ath-
letes may therefore benefit from additional supplements to help 
maintain homeostasis with adequate nutrients and energy in specific 
circumstances, especially where food intake or choice is restricted. 
For this reason, dietary supplements have been used by athletes for 
many years to boost, even by small margins, their strength and per-
formance. [2-4] Pressure to perform and the potential rewards coupled 
with success are powerful driving forces for many top athletes to 
continue striving for that chemical competitive edge. For this pur-
pose, they use these dietary supplements as part of their regular 
training or competition routine, even if the rationale for using these 
products is not always underpinned by solid evidence-based res-
earch.[1] Supplements commonly used include vitamins, minerals, 
protein, creatine and various ergogenic compounds. While some 
supplements indeed enhance athletic performance, many have no 
proven benefits, are of uncertain content and purity, and may have 
serious systemic adverse effects, including death. 
The practice of using dietary supplements among the population 
at large and athletes at all levels of competition has led to a huge, 
continuously growing, multibillion dollar industry with a worldwide 
market estimated at more than $142 billion in 2011 and expected to 
rise to $205 billion by 2017.[5] Coupled with aggressive marketing 
techniques in which bold as well as unsubstantiated claims are 
frequently made, this explosive growth has been further fuelled in 
many countries worldwide which have acts similar to the Dietary 
Supplement Health and Education Act (DSHEA), which was passed by 
the US Congress in 1994. In essence, these acts allow substances that 
are marketed as dietary supplements to be regulated as foods rather 
than as pharmaceuticals. A dietary supplement is a product taken 
orally that contains a ‘dietary ingredient’ intended to supplement the 
diet. The ‘dietary ingredients’ in these products may include vitamins, 
minerals, herbs or other botanicals, amino acids, and substances 
such as enzymes, organ tissues, glandulars and metabolites.[6] Dietary 
supplements can be extracts or concentrates, and may be found in 
many forms such as tablets, capsules, softgels, gelcaps, liquids or 
powders. They can also be in other forms, such as a bar, but if they 
are, information on the label must not represent the product as a 
conventional food or a sole item of a meal or diet.[6] Whatever their 
form may be, the DSHEA places dietary supplements in a special 
category under the general umbrella of ‘foods’, not drugs, and requires 
that every supplement be labelled a dietary supplement.[6] Other than 
for pharmaceuticals, in which regulatory authorities scrutinise data 
on safety and efficacy before giving marketing approval, supplement 
manufacturers do not have to prove efficacy for their products, 
providing that they do not claim that their preparations can be used 
to diagnose, cure, mitigate, treat or prevent diseases. Furthermore, 
manufacturers of dietary supplements do not have to demonstrate 
their safety, and the burden rests on regulatory authorities to show 
that a particular product is harmful before steps can be taken to 
ensure its removal from the market.
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These dietary supplement regulations have facilitated their avail-
ability not only to the population at large and noncompeting ama-
teurs, but especially to professional athletes in whom their use, often 
in megadoses, is widespread.[7,8] Estimated use in the latter group 
varies between 44% and 100%; however, this very much depends 
not only on the type of sport but also on the level of competition 
and age and gender of the athletes.[8-11] Large quantities of nutrients, 
commonly found in normal human diets, are consumed without there 
being much knowledge of possible health risks and the maximum 
daily safe doses involved. Over the past decade, a new hazard related 
to dietary supplement use has been identified in that some products, 
marketed under the aegis of the regulatory requirements for foods, 
have been shown to contain unapproved pharmaceutically active 
ingredients. These dietary regulations have allowed manufacturers 
to bypass the necessity of providing safety and efficacy data for their 
products. It is of great concern that a wide variety of dietary supp-
lements contain ingredients not adequately chemically identified on 
their packaging labels. These ingredients, which are sometimes listed 
as ‘natural’, ‘herbal’ or otherwise, may constitute prohibited substances. 
They may have inadvertently entered the product, possibly as a result 
of accidental cross-contamination in manufacturing plants, or may 
have been intentionally added to the supplement, posing a potential 
health hazard to all consumers.[4,12] While concentrations of these 
non-approved substances may be too small to achieve any health or 
performance-enhancing effects, they may be large enough for athletes 
to fail a doping test, and scandals appear to be more fre quent.[4] 
In recent years, there has been an increase in the number of dietary 
supplements containing unapproved pharmaceutical ingredients, 
recalled by the Food and Drug Administration.[13] With as many as 
150 million citizens in the USA consuming dietary supplements in 
some form or another, the challenges that are posed by this growing 
and unregulated industry are enormous. 
Ephedrine and pseudoephedrine
Although stimulants can easily be detected in laboratories, they 
are still popular among athletes. Because the list of legal and illegal 
stimulants is extensive, only a selection will be discussed here. 
Studies have shown that certain dietary supplements have con -
tained prohibited substances such as ephedrine and its analogues 
(pseudoephedrine, methylephedrine, etc.), caffeine, 3,4-methylene-
dioxy-N-methylamphetamine (MDMA, or ‘ecstasy’) and other 
amphetamine-related compounds, which may or may not be de-
clared on packaging labels.[12] Ephedrine and its congeners are used 
as nasal decongestants and as pressor agents for hypotension. While 
caffeine is no longer considered a prohibited substance by the World 
Anti-doping Agency (WADA) since 2004, the use of ephedrine and 
its analogues and MDMA is banned during competition by this 
organisation.[14] On certain food supplement labels, natural sources 
of ephedrine, e.g. Ephedra sinica – a species of ephedra (ma huang), 
which contains the alkaloids ephedrine and pseudoephedrine – are 
mentioned instead of the chemical entities of ephedrine and its ana-
logues. Similarly, synephrine is obtained from Citrus aurantium. 
Both plant products have been found in dietary supplements that 
were labelled as ‘ephedrine free’. Apart from the doping infringement 
aspects of supplements containing prohibited stimulants, there are 
potential health risks involved that should not be ignored. Ephedrine 
has structural similarities with amphetamine and therefore has 
similar modes of action and a comparable side-effect profile. Both 
ephedrine and pseudoephedrine are stimulants, but they affect 
physical achievement differently. Ephedrine adversely affects running 
time over 10 km, but anaerobic performance of athletes increases.[15,16] 
Supporting evidence found in a meta-analysis of eight studies was, 
however, insufficient to demonstrate clear benefits in performance 
with ephedrine.[17] Similarly, improvements in fatigue and cycling 
performance with pseudoephedrine ingestion could not be found, 
but in a limited study an improvement in running times over 1.5 km 
following the use of this pharmaceutical agent was shown.[18-20]
Adverse effects of ephedrine may be serious. A two- to three-
fold risk of anxiety, increased irritability and agitation (psychiatric 
symptoms), insomnia, tremors (autonomic system symptoms) and 
heart palpitations (cardiac symptoms) were found on analysis of 
71 case reports and 50 clinical trials.[17] In the foregoing analysis of 
cases of death, myocardial infarctions, cerebrovascular accidents, 
seizures and psychoses were found in some reports. Regarding 
pseudoephedrine anxiety, gastrointestinal disturbances and tremors 
have been reported.[21] Both ephedrine and pseudoephedrine have 
been declared prohibited substances by the WADA.[14]
Sibutramine
Dietary supplements adulterated with sibutramine, an anti-obesity 
agent, which do not mention the presence of this compound on the 
packaging label, have also appeared on the market. Sibutramine has 
been found in products advertised as ‘pure herbal’ slimming capsules 
and ‘natural’ tea.[22-24] Urinary metabolites of sibutramine were found 
in detectable quantities 50 hours after administration of a single ‘dose’ 
of tea to a volunteer.[24] This synthetic anorectic drug, which only has 
market approval as a prescription anti-obesity agent, has been on the 
WADA prohibited list since 2006. Furthermore, market withdrawal of 
sibutramine was recommended by the European Medicines Agency 
at the beginning of 2010. This agent produces severe systemic adverse 
effects, blood pressure elevation and cardiac effects (tachycardia), 
and patients using sibutramine are required to be monitored by a 
physician experienced in the treatment of obesity and familiar with 
this agent, on a regular basis.
Methylhexaneamine 
Methylhexaneamine, a stimulant originally intended to be market-
ed as a nasal decongestant, has been detected as an ingredient of 
dietary supplements and was declared a prohibited compound by 
the WADA in 2009.[25] The serious adverse effects of this stimulant 
have recently been highlighted by a case report on the death of 
two US soldiers who were taking commercially available dietary 
supplements that contained methylhexaneamine. Both soldiers 
collapsed from cardiac arrest during physical exertion and ulti-
mately died.[26] The issues surrounding this stimulant have been 
complicated by the fact that methylhexaneamine is found on package 
labels under a very wide variety of chemical and non-chemical 
names, e.g. 1,3-dimethylamylamine, 1,3-dimethylpentylamine, 
2-amino-4-methylhexane, 2-hexanamine, 4-methyl-2-hexanamine, 
4-methyl-2-hexylamine, 4-methylhexan-2-amine, dimethylamyl -
amine, methyl hexaneamine, dimethylpentylamine, floradrene, forthan, 
forthane, fouramin, geranamine, geranium extract, geranium flower 
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extract, geranium oil, geranium stems and leaves, metexaminum, 
methexaminum, etc. Only the names methylhexaneamine and di-
methy lpentylamine appear on the WADA 2011 list of prohibited 
agents, creating even further confusion among consumers and 
complicating identification. While geranium root extract or geranium 
oil are mentioned as natural sources of methylhexaneamine, the 
presence of this compound in these plant products could not be 
demonstrated on analysis, strengthening the suspicion that it was 
added during or after the manufacturing process.[27]
Conclusion
While food supplements and pharmaceutical agents may enhance 
strength and performance of athletes, there is insufficient scientific 
data to support this theory. Although stimulants have been widely 
used among athletes for performance enhancement, these substances 
are prohibited by the WADA. In addition, ingestion of stimulants 
via accidentally or intentionally contaminated dietary supplements 
may lead to failed doping tests and its consequences. The presence 
of stimulants in nutritional supplements may also lead to serious 
systemic adverse effects; athletes, coaches and sports doctors should 
be aware of these pitfalls when using or advising on the intake of these 
products. The risk of accidental ingestion of forbidden substances 
from dietary supplements can be diminished by using ‘safe’ products 
listed on databases such as those available in the Netherlands and 
Germany.[12]
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